ZYUS Life Sciences Corporation ZYUS.V
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · zyus.com
ZYUS Life Sciences Corporation is a Canadian life sciences company focused on developing and commercializing novel cannabinoid-based pharmaceutical drug candidates for pain management. The company holds multiple Health Canada licenses including a Cannabis Drug License, and operates a pharmaceutical-grade cannabinoid formulation facility in Saskatoon, Saskatchewan, pursuing non-opioid-based pharmaceutical solutions.
Key ratios
FreeCashFlowOnSale TTM -23.09
FreeCashFlowOnSale 2024 -20.63
FreeCashFlowOnSale 2023 -51.93
FreeCashFlowOnSale 2022 -34.01
ReturnOnAssets TTM -0.41
ReturnOnAssets 2024 -0.35
ReturnOnAssets 2023 -0.23
ReturnOnAssets 2022 -0.15
ReturnOnEquity TTM -35.17
ReturnOnEquity 2024 -3.8
ReturnOnEquity 2023 -3.06
ReturnOnEquity 2022 -1.65
TotalRevenueYoYGrowth TTM 0.03
TotalRevenueYoYGrowth 2024 0.37
TotalRevenueYoYGrowth 2023 0.18
TotalRevenueYoYGrowth 2022 0.44
Recent news
ZYUS Life Sciences Corporation Announces Revocation of Failure-to-File Cease Trade Order
2026-07-22 · CNW
ZYUS Life Sciences Corporation Announces Closing of Sixth Tranche of Secured Loan Financing
2026-07-21 · CNW
ZYUS Announces Database Lock for its Phase 2a UTOPIA-1 Trial, CFO Transition and Continuous Disclosure Update
2026-07-20 · CNW
ZYUS Life Sciences Corporation Announces Closing of Fifth Tranche of Secured Loan Financing
2026-07-03 · Newswire (CNW)
ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing
2026-06-17 · Globe and Mail
ZYUS Life Sciences Corporation Announces Closing of First Tranche of Secured Loan Financing and Provides an Update on its Annual Filings
2026-05-20 · Stockhouse
ZYUS Life Sciences Provides an Update on Its Unit Offering
2026-04-10 · Newswire Canada
ZYUS Life Sciences Announces Closing of Debt Financing
2026-03-05 · Newswire Canada